Medical/Pharmaceuticals

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

TAMPA, Fla., May 1, 2023 /PRNewswire/ -- The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc's novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary ar...

2023-05-01 18:30 2862

Zimmer Biomet Announces Acquisition of OSSIS

SINGAPORE, May 1, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as wel...

2023-05-01 12:00 5290

GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023

–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date – – Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innova...

2023-05-01 11:00 3263

ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller

MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalT...

2023-05-01 08:58 2720

OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products

SHANGHAI, April 29, 2023 /PRNewswire/ -- On April 21, 2023, OBiO Technology ( Shanghai) Corp., Ltd. (OBiO) announced a strategic agreement of commercial manufacturing collaboration with CHINAGENE. Under the agreement, OBiO will provide holistic contract development and manufacturing services to CH...

2023-04-29 23:20 4338

ISS Collaboration - Singleron Biotechnologies GmbH joined the pursuit of "Reaching for the Stars"

MSIDA, Malta, April 28, 2023 /PRNewswire/ -- Yesterday, the celebrations for the MALETH project took place with a special keynote presentation from Dr.James Green, NASA's Former Chief Scientist. From Singleron, Dr. Samuel Kerr joined to present the yeast research studies aboard the International ...

2023-04-28 20:56 2139

HanAll Biopharma Reports First Quarter Results and Provides Business Update

* Financial results for the first quarter ended with revenue of KRW 28.8 billion, up by 20 percent compared to the same period in 2022 * HanAll made a strong start to 2023 with positive Phase 3 study results of anti-FcRn asset batoclimab for the treatment of generalized myasthenia gravis in C...

2023-04-28 19:00 2975

IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study

SAN DIEGO, SHANGHAI and SYDNEY, April 28, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced positive topline results from a Phase 1 study evaluating IMG-004 in healthy participants. IMG-004 is a potent, non-covalent, reversible, and brain permeable third-generation Br...

2023-04-28 17:00 1876

United Imaging Healthcare delivers its first annual report since going public, with revenue growth of nearly 30% in 2022

Along with the publication of its 2022 annual report and its first quarter report for 2023, United Imaging Healthcare released its ESG report today. SHANGHAI, April 28, 2023 /PRNewswire/ -- United Imaging Healthcare achieved a YoY revenue growth of 27.36 %, a figure published in the company's 202...

2023-04-28 15:53 1829

WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability

* The Report outlines new goals of net-zero GHG emissions across all operations by 2050 and a 10% reduction of waste intensity by 2027 compared with 2022. * The Company makes remarkable progress on environmental goals, achieving its water consumption intensity-reduction target in 2022, well a...

2023-04-28 14:43 2972

European Wellness Collaborates with Heidelberg University in Journal Publications of "Synergistic Anti-Ageing Through Senescent Cells Specific Reprogramming"

HEIDELBERG, Germany, April 28, 2023 /PRNewswire/ -- European Wellness Academy (EWA), an educational arm of European Wellness Biomedical Group (EW Group), has collaborated with Heidelberg University on journal publication. The research project, titled "Synergistic Anti-Ageing Through Senescent Cel...

2023-04-28 11:58 2799

HOYA Vision Care Elevates Children's Protection Against Myopia & Intensive Light With MiYOSMART Sun Lenses

SINGAPORE, April 28, 2023 /PRNewswire/ -- HOYA Vision Care , a leader in optical technology innovation, has launched MiYOSMART Sun spectacle lenses inSingapore, which are designed to be effective and non-invasive protection against myopia for children. The photochrom...

2023-04-28 11:18 2792

Brii Bio Publishes 2022 Environmental, Social and Governance Report

Brii Bio receives an "A" grade in the latest MSCI ESG Rating DURHAM, N.C. and BEIJING, April 28, 2023 /PRNewswire/ -- Brii Biosciences Limited  ("Brii Bio" or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health ...

2023-04-28 09:00 3037

Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio

- Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech investment firm - Targeting the KRW 146 trillion global autoimmune disease market with partner who has top global drug development expertis...

2023-04-28 08:58 2154

OrthAlign's 50th Patent Affirms Position as A Global Leader in Surgical Navigation

ALISO VIEJO, Calif., April 28, 2023 /PRNewswire/ -- OrthAlign® Inc., a global leader in orthopedic surgical navigation technology, continues to expand its IP portfolio, with its 50th patent being issued. OrthAlign pioneered and continues to enhance surgical navigation solutions proven to enable a...

2023-04-28 04:33 2355

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine

GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc.(the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance from the Uni...

2023-04-28 00:29 3127

Steakholder Foods® 3D Bio-Prints First Ready-to-Cook Cultivated Grouper Fish

Steakholder Foods 3D bio-printed the world's first cultivated fish fillet: * The Company has reached a significant milestone by successfully customizing bio-inks utilizing grouper cells provided by Umami Meats' to print a cultivated grouper product – a significant step towards the commercializa...

2023-04-27 23:50 4794

Ubie signs a broad collaboration agreement with Takeda Pharmaceuticals to promote digital transformation

- Aims to guide patients with rare and gastrointestinal diseases to appropriate medical care 〜Ubie will build on its achievements in the early detection of HAE and expand its collaboration with Takeda Pharmaceuticals to benefit patients in broader disease areas〜 NEW YORK, April 27, 2023 /PRNews...

2023-04-27 23:00 1894

Healint announces a collaboration with Saitama Medical University Hospital, Japan, to verify AI diagnosis of Migraine

PALO ALTO, Calif., April 27, 2023 /PRNewswire/ -- Saitama Medical University Hospital and Healint launched one of the world's first clinical studies titled "Verification of Headache AI diagnosis by using Electronic Headache Diary in Telemedicine". About 20 renowned headache specialists partici...

2023-04-27 21:15 2067

Yuyu Pharma, Dry Eye Pipeline Mechanism of Action and Pre-clinical Results Published

SEOUL, South Korea, April 27, 2023 /PRNewswire/ -- At ARVO 2023, Yuyu Pharma unveiled the results of its mechanism of action and head-to- head studies for its dry eye treatment peptide (project name: YP-P10). ARVO is the world's largest ophthalmic society and held its annual meeting inNew Orleans...

2023-04-27 21:00 2090
1 ... 204205206207208209210 ... 614